These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14742245)

  • 21. Oxidative stress in retinoblastoma: correlations with clinicopathologic features and tumor invasiveness.
    Deepa PR; Nalini V; Mallikarjuna K; Vandhana S; Krishnakumar S
    Curr Eye Res; 2009 Dec; 34(12):1011-8. PubMed ID: 19958119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Fas ligand in retinoblastoma.
    Krishnakumar S; Kandalam M; Mohan A; Iyer A; Venkatesan N; Biswas J; Shanmugam MP
    Cancer; 2004 Oct; 101(7):1672-6. PubMed ID: 15378505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model.
    Jockovich ME; Suarez F; Alegret A; Piña Y; Hayden B; Cebulla C; Feuer W; Murray TG
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5371-6. PubMed ID: 18055783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical expression of CD117 and vascular endothelial growth factor in retinoblastoma: possible targets of new therapies.
    Youssef NS; Said AM
    Int J Clin Exp Pathol; 2014; 7(9):5725-37. PubMed ID: 25337214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of nitric oxide synthases and nitrotyrosine in retinoblastoma.
    Adithi M; Nalini V; Krishnakumar S
    Cancer; 2005 Apr; 103(8):1701-11. PubMed ID: 15754329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoblastomas in Ibadan Nigeria: II--Clinicopathologic features.
    Akang EE; Ajaiyeoba IA; Campbell OB; Olurin IO; Aghadiuno PU
    West Afr J Med; 2000; 19(1):6-11. PubMed ID: 10821078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation.
    Bellan C; De Falco G; Tosi GM; Lazzi S; Ferrari F; Morbini G; Bartolomei S; Toti P; Mangiavacchi P; Cevenini G; Trimarchi C; Cinti C; Giordano A; Leoncini L; Tosi P; Cottier H
    Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3602-8. PubMed ID: 12454024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclooxygenase-2 directly induces MCF-7 breast tumor cells to develop into exponentially growing, highly angiogenic and regionally invasive human ductal carcinoma xenografts.
    Robertson FM; Mallery SR; Bergdall-Costell VK; Cheng M; Pei P; Prosperi JR; Ferrari M
    Anticancer Res; 2007; 27(2):719-27. PubMed ID: 17465194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 and p21waf-1 expression correlates with apoptosis or cell survival in poorly differentiated, but not well-differentiated, retinoblastomas.
    Divan A; Lawry J; Dunsmore IR; Parsons MA; Royds JA
    Cancer Res; 2001 Apr; 61(7):3157-63. PubMed ID: 11306502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoblastoma. The relationship of proliferating cells to blood vessels.
    Burnier MN; McLean IW; Zimmerman LE; Rosenberg SH
    Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):2037-40. PubMed ID: 2211000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical predictors of high risk histopathology in retinoblastoma.
    Kashyap S; Meel R; Pushker N; Sen S; Bakhshi S; Sreenivas V; Sethi S; Chawla B; Ghose S
    Pediatr Blood Cancer; 2012 Mar; 58(3):356-61. PubMed ID: 21721113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combretastatin A-4 prodrug in the treatment of a murine model of retinoblastoma.
    Escalona-Benz E; Jockovich ME; Murray TG; Hayden B; Hernandez E; Feuer W; Windle JJ
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):8-11. PubMed ID: 15623747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
    Stitt AW; Simpson DA; Boocock C; Gardiner TA; Murphy GM; Archer DB
    J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathologic features of retinoblastoma and expression of VEGF and Ki-67 after comprehensive treatment].
    Xue K; Qian J; Bi YW; Yao YQ; Yuan YF; DA CD
    Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):134-41. PubMed ID: 21426843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracranial malignancy in patients with bilateral retinoblastoma.
    Donoso LA; Shields JA; Felberg NT; Martyn LJ; Truex RC; D'Cruz CA
    Retina; 1981; 1(1):67-74. PubMed ID: 15633409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CT and MRI features of recurrent tumors and second primary neoplasms in pediatric patients with retinoblastoma.
    Tateishi U; Hasegawa T; Miyakawa K; Sumi M; Moriyama N
    AJR Am J Roentgenol; 2003 Sep; 181(3):879-84. PubMed ID: 12933497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leucine-Rich α-2-Glycoprotein-1 (LRG-1) Expression in Retinoblastoma.
    Amer R; Tiosano L; Pe'er J
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):685-692. PubMed ID: 29392314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of Fas expression in retinoblastoma.
    Shanmugam MP; Lakshmi A; Biswas J; Krishnakumar S
    Ocul Immunol Inflamm; 2003 Jun; 11(2):107-13. PubMed ID: 14533029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late-onset retinoblastoma in a well-functioning fellow eye.
    de Jong PT; Mooy CM; Stoter G; Eijkenboom WM; Luyten GP
    Ophthalmology; 2006 Jun; 113(6):1040-4. PubMed ID: 16631255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased hypoxia following vessel targeting in a murine model of retinoblastoma.
    Boutrid H; Piña Y; Cebulla CM; Feuer WJ; Lampidis TJ; Jockovich ME; Murray TG
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5537-43. PubMed ID: 19578014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.